Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO1 | P15559 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.51 |
| ▸ | PPARG | P37231 | 1/20 | 0.51 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.51 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | NPY1R | P25929 | 1/20 | 0.48 |
| ▸ | NPY2R | P49146 | 1/20 | 0.48 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.47 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 7/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.47 |
| ▸ | CASP1 | P29466 | 6/20 | 0.47 |
| ▸ | CASP7 | P55210 | 5/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15937803 | 1.00 | NQO1 (0.51) | NQO1L3MBTL1PPARGNCOA2NCOA1 | |
| SCHEMBL7103558 | 0.85 | CYP1A2 (0.63) | L3MBTL1PPARGNCOA2NCOA1NPSR1 | |
| SCHEMBL7103588 | 0.82 | L3MBTL1 (0.46) | NQO1L3MBTL1PPARGNCOA2NCOA1 | |
| SCHEMBL7433184 | 0.82 | ALDH1A1 (0.58) | NQO1L3MBTL1PPARGNCOA2NCOA1 | |
| SCHEMBL1478806 | 0.81 | THRB (0.51) | NQO1L3MBTL1PPARGNCOA2NCOA1 | |
| SCHEMBL1478811 | 0.81 | THRB (0.51) | NQO1L3MBTL1PPARGNCOA2NCOA1 | |
| SCHEMBL9239060 | 0.79 | CYP1A1 (0.69) | CYP1A1CYP1A2CYP1B1CYP3A4NFE2L2 | |
| SCHEMBL9239065 | 0.79 | CYP1A1 (0.69) | CYP1A1CYP1A2CYP1B1CYP3A4NFE2L2 | |
| SCHEMBL15938593 | 0.78 | ALDH1A1 (0.39) | NQO1L3MBTL1PPARGNCOA2NCOA1 | |
| SCHEMBL15938592 | 0.78 | ALDH1A1 (0.39) | NQO1L3MBTL1PPARGNCOA2NCOA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10071067-B2 | Anise flavored medication | THE PROCTER & GAMBLE COMPANY (US) | 2018-09-11 | — | — | US | claimed |
| US-20180064661-A1 | Anise Flavored Medication | PROCTER & GAMBLE (US) | 2018-03-08 | — | — | US | claimed |
| US-9839620-B2 | Anise flavored medication | THE PROCTER & GAMBLE COMPANY (US) | 2017-12-12 | — | — | US | claimed |
| US-20160361277-A1 | Anise Flavored Medication | PROCTER & GAMBLE (US) | 2016-12-15 | — | — | US | claimed |
| US-10588872-B2 | Anise flavored medication | THE PROCTER & GAMBLE COMPANY (US) | 2020-03-17 | — | — | US | disclosed |
| US-20180344670-A1 | Anise Flavored Medication | PROCTER & GAMBLE (US) | 2018-12-06 | — | — | US | disclosed |
| US-10071067-B2 | Anise flavored medication | THE PROCTER & GAMBLE COMPANY (US) | 2018-09-11 | — | — | US | disclosed |
| US-20180064661-A1 | Anise Flavored Medication | PROCTER & GAMBLE (US) | 2018-03-08 | — | — | US | disclosed |
| US-9839620-B2 | Anise flavored medication | THE PROCTER & GAMBLE COMPANY (US) | 2017-12-12 | — | — | US | disclosed |
| US-20160361277-A1 | Anise Flavored Medication | PROCTER & GAMBLE (US) | 2016-12-15 | — | — | US | disclosed |
| US-9457085-B2 | Anise flavored medication | THE PROCTER & GAMBLE COMPANY (US) | 2016-10-04 | — | — | US | disclosed |
| EP-2956120-A1 | ANISE FLAVORED MEDICATION | The Procter & Gamble Company (US) | 2015-12-23 | — | — | EP | disclosed |
| WO-2014127118-A1 | ANISE FLAVORED MEDICATION | THE PROCTER & GAMBLE COMPANY (US) | 2014-08-21 | — | — | WO | disclosed |
| US-20140228391-A1 | Anise Flavored Medication | THE PROCTER & GAMBLE COMPANY (US) | 2014-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180344670-A1 | Anise Flavored Medication | ADRB1, ADRA1B, ADRA2B | NQO1 1554/4885L3MBTL1 2589/4885PPARG 789/4885 |
| US-20160361277-A1 | Anise Flavored Medication | ADRB1, ADRA1B, ADRA2B | NQO1 1554/4885L3MBTL1 2589/4885PPARG 789/4885 |
| US-10071067-B2 | Anise flavored medication | ADRB1, ADRA1B, ADRA2B | NQO1 1554/4885L3MBTL1 2589/4885PPARG 789/4885 |
| US-20180064661-A1 | Anise Flavored Medication | ADRB1, ADRA1B, ADRA2B | NQO1 1554/4885L3MBTL1 2589/4885PPARG 789/4885 |
| US-10588872-B2 | Anise flavored medication | ADRB1, ADRA1B, ADRA2B | NQO1 1554/4885L3MBTL1 2589/4885PPARG 789/4885 |
| US-20140228391-A1 | Anise Flavored Medication | ADRB1, ADRA1B, ADRA2B | NQO1 1554/4885L3MBTL1 2589/4885PPARG 789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.